Selected research
Industry Research
Topical Antibiotics Industry Research Report 2026
Market perspective
The global Topical Antibiotics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Topical Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Topical Antibiotics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Topical Antibiotics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Topical Antibiotics include Novartis AG, Pfizer, Inc, GlaxoSmithKline plc, Taro Pharmaceutical Industries Ltd., Perrigo Company plc, Medimetriks Pharmaceuticals, Inc., Mayne Pharma Group Limited., Bausch Health Companies, Inc and Almirall, S.A., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Topical Antibiotics market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Topical Antibiotics Market by Company
Novartis AG
Pfizer, Inc
GlaxoSmithKline plc
Taro Pharmaceutical Industries Ltd.
Perrigo Company plc
Medimetriks Pharmaceuticals, Inc.
Mayne Pharma Group Limited.
Bausch Health Companies, Inc
Almirall, S.A.
Topical Antibiotics Segment by Type
Powder
Creams
Gels
Ointments
Others
Topical Antibiotics Segment by Application
Eye Infection
Skin Infection
Bromhidrosis
Others
Topical Antibiotics Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Topical Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Topical Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Topical Antibiotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Topical Antibiotics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Topical Antibiotics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Topical Antibiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Powder
- Creams
- Gels
- Ointments
- Others
Applications
- Eye Infection
- Skin Infection
- Bromhidrosis
- Others
Companies covered
- Novartis AG
- Pfizer, Inc
- GlaxoSmithKline plc
- Taro Pharmaceutical Industries Ltd.
- Perrigo Company plc
- Medimetriks Pharmaceuticals, Inc.
- Mayne Pharma Group Limited.
- Bausch Health Companies, Inc
- Almirall, S.A.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Topical Antibiotics Market Size (2021-2032)
- 2.2.2 Global Topical Antibiotics Sales (2021-2032)
- 2.2.3 Global Topical Antibiotics Market Average Price (2021-2032)
- 2.3 Topical Antibiotics by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Powder
- 2.3.3 Creams
- 2.3.4 Gels
- 2.3.5 Ointments
- 2.3.6 Others
- 2.4 Topical Antibiotics by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Eye Infection
- 2.4.3 Skin Infection
- 2.4.4 Bromhidrosis
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Topical Antibiotics Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Topical Antibiotics Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Topical Antibiotics Revenue of Manufacturers (2021-2026)
- 3.4 Global Topical Antibiotics Average Price by Manufacturers (2021-2026)
- 3.5 Global Topical Antibiotics Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Topical Antibiotics, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Topical Antibiotics, Product Type & Application
- 3.8 Global Manufacturers of Topical Antibiotics, Established Date
- 3.9 Global Topical Antibiotics Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novartis AG
- 4.1.1 Novartis AG Company Information
- 4.1.2 Novartis AG Business Overview
- 4.1.3 Novartis AG Topical Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novartis AG Topical Antibiotics Product Portfolio
- 4.1.5 Novartis AG Recent Developments
- 4.2 Pfizer, Inc
- 4.2.1 Pfizer, Inc Company Information
- 4.2.2 Pfizer, Inc Business Overview
- 4.2.3 Pfizer, Inc Topical Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Pfizer, Inc Topical Antibiotics Product Portfolio
- 4.2.5 Pfizer, Inc Recent Developments
- 4.3 GlaxoSmithKline plc
- 4.3.1 GlaxoSmithKline plc Company Information
- 4.3.2 GlaxoSmithKline plc Business Overview
- 4.3.3 GlaxoSmithKline plc Topical Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 GlaxoSmithKline plc Topical Antibiotics Product Portfolio
- 4.3.5 GlaxoSmithKline plc Recent Developments
- 4.4 Taro Pharmaceutical Industries Ltd.
- 4.4.1 Taro Pharmaceutical Industries Ltd. Company Information
- 4.4.2 Taro Pharmaceutical Industries Ltd. Business Overview
- 4.4.3 Taro Pharmaceutical Industries Ltd. Topical Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Taro Pharmaceutical Industries Ltd. Topical Antibiotics Product Portfolio
- 4.4.5 Taro Pharmaceutical Industries Ltd. Recent Developments
- 4.5 Perrigo Company plc
- 4.5.1 Perrigo Company plc Company Information
- 4.5.2 Perrigo Company plc Business Overview
- 4.5.3 Perrigo Company plc Topical Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Perrigo Company plc Topical Antibiotics Product Portfolio
- 4.5.5 Perrigo Company plc Recent Developments
- 4.6 Medimetriks Pharmaceuticals, Inc.
- 4.6.1 Medimetriks Pharmaceuticals, Inc. Company Information
- 4.6.2 Medimetriks Pharmaceuticals, Inc. Business Overview
- 4.6.3 Medimetriks Pharmaceuticals, Inc. Topical Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Medimetriks Pharmaceuticals, Inc. Topical Antibiotics Product Portfolio
- 4.6.5 Medimetriks Pharmaceuticals, Inc. Recent Developments
- 4.7 Mayne Pharma Group Limited.
- 4.7.1 Mayne Pharma Group Limited. Company Information
- 4.7.2 Mayne Pharma Group Limited. Business Overview
- 4.7.3 Mayne Pharma Group Limited. Topical Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Mayne Pharma Group Limited. Topical Antibiotics Product Portfolio
- 4.7.5 Mayne Pharma Group Limited. Recent Developments
- 4.8 Bausch Health Companies, Inc
- 4.8.1 Bausch Health Companies, Inc Company Information
- 4.8.2 Bausch Health Companies, Inc Business Overview
- 4.8.3 Bausch Health Companies, Inc Topical Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Bausch Health Companies, Inc Topical Antibiotics Product Portfolio
- 4.8.5 Bausch Health Companies, Inc Recent Developments
- 4.9 Almirall, S.A.
- 4.9.1 Almirall, S.A. Company Information
- 4.9.2 Almirall, S.A. Business Overview
- 4.9.3 Almirall, S.A. Topical Antibiotics Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Almirall, S.A. Topical Antibiotics Product Portfolio
- 4.9.5 Almirall, S.A. Recent Developments
5 Global Topical Antibiotics Market Scenario by Region
- 5.1 Global Topical Antibiotics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Topical Antibiotics Sales by Region: 2021-2032
- 5.2.1 Global Topical Antibiotics Sales by Region: 2021-2026
- 5.2.2 Global Topical Antibiotics Sales by Region: 2027-2032
- 5.3 Global Topical Antibiotics Revenue by Region: 2021-2032
- 5.3.1 Global Topical Antibiotics Revenue by Region: 2021-2026
- 5.3.2 Global Topical Antibiotics Revenue by Region: 2027-2032
- 5.4 North America Topical Antibiotics Market Facts & Figures by Country
- 5.4.1 North America Topical Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Topical Antibiotics Sales by Country (2021-2032)
- 5.4.3 North America Topical Antibiotics Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Topical Antibiotics Market Facts & Figures by Country
- 5.5.1 Europe Topical Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Topical Antibiotics Sales by Country (2021-2032)
- 5.5.3 Europe Topical Antibiotics Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Topical Antibiotics Market Facts & Figures by Country
- 5.6.1 Asia Pacific Topical Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Topical Antibiotics Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Topical Antibiotics Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Topical Antibiotics Market Facts & Figures by Country
- 5.7.1 South America Topical Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Topical Antibiotics Sales by Country (2021-2032)
- 5.7.3 South America Topical Antibiotics Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Topical Antibiotics Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Topical Antibiotics Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Topical Antibiotics Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Topical Antibiotics Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Topical Antibiotics Sales by Type (2021-2032)
- 6.1.1 Global Topical Antibiotics Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Topical Antibiotics Sales Market Share by Type (2021-2032)
- 6.2 Global Topical Antibiotics Revenue by Type (2021-2032)
- 6.2.1 Global Topical Antibiotics Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Topical Antibiotics Revenue Market Share by Type (2021-2032)
- 6.3 Global Topical Antibiotics Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Topical Antibiotics Sales by Application (2021-2032)
- 7.1.1 Global Topical Antibiotics Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Topical Antibiotics Sales Market Share by Application (2021-2032)
- 7.2 Global Topical Antibiotics Revenue by Application (2021-2032)
- 7.2.1 Global Topical Antibiotics Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Topical Antibiotics Revenue Market Share by Application (2021-2032)
- 7.3 Global Topical Antibiotics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Topical Antibiotics Value Chain Analysis
- 8.1.1 Topical Antibiotics Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Topical Antibiotics Production Mode & Process
- 8.2 Topical Antibiotics Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Topical Antibiotics Distributors
- 8.2.3 Topical Antibiotics Customers
9 Global Topical Antibiotics Analyzing Market Dynamics
- 9.1 Topical Antibiotics Industry Trends
- 9.2 Topical Antibiotics Industry Drivers
- 9.3 Topical Antibiotics Industry Opportunities and Challenges
- 9.4 Topical Antibiotics Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst